IL143280A0 - Use of riluzole for treating acoustic traumas - Google Patents

Use of riluzole for treating acoustic traumas

Info

Publication number
IL143280A0
IL143280A0 IL14328099A IL14328099A IL143280A0 IL 143280 A0 IL143280 A0 IL 143280A0 IL 14328099 A IL14328099 A IL 14328099A IL 14328099 A IL14328099 A IL 14328099A IL 143280 A0 IL143280 A0 IL 143280A0
Authority
IL
Israel
Prior art keywords
riluzole
treating acoustic
traumas
acoustic traumas
treating
Prior art date
Application number
IL14328099A
Other languages
English (en)
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of IL143280A0 publication Critical patent/IL143280A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
IL14328099A 1998-12-15 1999-12-13 Use of riluzole for treating acoustic traumas IL143280A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9815834A FR2787028B1 (fr) 1998-12-15 1998-12-15 Utilisation du riluzole dans le traitement des traumatismes acoustiques
PCT/FR1999/003108 WO2000035447A1 (fr) 1998-12-15 1999-12-13 Utilisation du riluzole dans le traitement des traumatismes acoustiques

Publications (1)

Publication Number Publication Date
IL143280A0 true IL143280A0 (en) 2002-04-21

Family

ID=9533998

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14328099A IL143280A0 (en) 1998-12-15 1999-12-13 Use of riluzole for treating acoustic traumas
IL143280A IL143280A (en) 1998-12-15 2001-05-21 Use of Rilozol in the preparation of drugs for the prevention and / or treatment of acoustic traumas

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL143280A IL143280A (en) 1998-12-15 2001-05-21 Use of Rilozol in the preparation of drugs for the prevention and / or treatment of acoustic traumas

Country Status (20)

Country Link
US (1) US6660757B2 (ja)
EP (1) EP1140080B1 (ja)
JP (2) JP4831866B2 (ja)
KR (1) KR100641473B1 (ja)
AT (1) ATE278401T1 (ja)
AU (1) AU773639B2 (ja)
BR (1) BR9916244A (ja)
CA (1) CA2355359C (ja)
CZ (1) CZ292078B6 (ja)
DE (1) DE69920959T2 (ja)
ES (1) ES2229796T3 (ja)
FR (1) FR2787028B1 (ja)
HU (1) HU228889B1 (ja)
IL (2) IL143280A0 (ja)
NO (1) NO326764B1 (ja)
PT (1) PT1140080E (ja)
SK (1) SK285206B6 (ja)
UA (1) UA72229C2 (ja)
WO (1) WO2000035447A1 (ja)
ZA (1) ZA200104827B (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2787028B1 (fr) * 1998-12-15 2002-10-18 Aventis Pharma Sa Utilisation du riluzole dans le traitement des traumatismes acoustiques
EP2076174A4 (en) * 2006-10-13 2012-10-24 Univ North Carolina APPARATUS AND METHOD FOR THE ACOUSTIC OR MECHANICAL STIMULATION OF A COCHLEA AND INTRACOCHLEAR RECORDING OF MECHANICAL OR ACOUSTIC EVOKED HEARING POTENTIALS IN THE COCHLEA
TW201039383A (en) * 2009-04-17 2010-11-01 Arima Optoelectronics Corp Semiconductor chip electrode structure and manufacturing method thereof
WO2016081466A1 (en) * 2014-11-21 2016-05-26 Biohaven Pharmaceutical Holding Company Ltd. Sublingual administration of riluzole
KR102580378B1 (ko) * 2014-11-21 2023-09-19 바이오하벤 파마슈티컬 홀딩 컴퍼니 엘티디. 릴루졸의 설하 제제
JP6999896B2 (ja) 2017-09-21 2022-01-19 学校法人慶應義塾 音響外傷難聴モデル動物の作製方法及びそれにより作製される音響外傷難聴モデル動物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2492258A1 (fr) 1980-10-17 1982-04-23 Pharmindustrie Nouveau medicament a base d'amino-2 trifluoromethoxy-6 benzothiazole
US4826860A (en) 1987-03-16 1989-05-02 Warner-Lambert Company Substituted 2-aminobenzothiazoles and derivatives useful as cerebrovascular agents
FR2619712B1 (fr) 1987-08-25 1990-08-31 Rhone Poulenc Sante Application de l'amino-2 trifluoromethoxy-6 benzothiazole pour obtenir un medicament destine au traitement de la schizophrenie
FR2619713B1 (fr) 1987-08-25 1990-08-31 Rhone Poulenc Sante Application de l'amino-2 trifluoromethoxy-6 benzothiazole pour obtenir un medicament destine au traitement des troubles du sommeil et de la depression
FR2699077B1 (fr) * 1992-12-16 1995-01-13 Rhone Poulenc Rorer Sa Application d'anticonvulsivants dans le traitement de lésions neurologiques liées à des traumatismes.
FR2700116B1 (fr) 1993-01-07 1995-02-03 Rhone Poulenc Rorer Sa Application d'anticonvulsivants comme radioprotecteurs.
FR2700117B1 (fr) 1993-01-07 1995-02-03 Rhone Poulenc Rorer Sa Application d'anticonvulsivants dans le traitement de la maladie de Parkinson et des syndromes parkinsoniens.
FR2702148B1 (fr) * 1993-03-05 1995-04-07 Rhone Poulenc Rorer Sa Application d'anticonvulsivants dans le traitement du neuro-sida.
FR2714828B1 (fr) * 1994-01-12 1996-02-02 Rhone Poulenc Rorer Sa Application du riluzole dans le traitement des maladies mitochondriales.
TW450807B (en) * 1995-09-15 2001-08-21 Pfizer Pharmaceutical compositions for treating tinnitus comprising neuroprotective agents
ATE212842T1 (de) * 1995-10-10 2002-02-15 Pfizer Quinoxalin-derivate zur behandlung von tinnitus
ZA9610745B (en) * 1995-12-22 1997-06-24 Warner Lambert Co 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists
FR2787028B1 (fr) * 1998-12-15 2002-10-18 Aventis Pharma Sa Utilisation du riluzole dans le traitement des traumatismes acoustiques

Also Published As

Publication number Publication date
NO20012777D0 (no) 2001-06-06
SK8242001A3 (en) 2001-12-03
EP1140080A1 (fr) 2001-10-10
JP5536722B2 (ja) 2014-07-02
CZ292078B6 (cs) 2003-07-16
JP4831866B2 (ja) 2011-12-07
AU773639B2 (en) 2004-05-27
EP1140080B1 (fr) 2004-10-06
US20020004516A1 (en) 2002-01-10
JP2011219497A (ja) 2011-11-04
FR2787028A1 (fr) 2000-06-16
DE69920959D1 (de) 2004-11-11
HUP0104698A2 (hu) 2002-04-29
PT1140080E (pt) 2005-01-31
UA72229C2 (en) 2005-02-15
ES2229796T3 (es) 2005-04-16
DE69920959T2 (de) 2005-09-01
CA2355359A1 (fr) 2000-06-22
ZA200104827B (en) 2002-09-13
NO20012777L (no) 2001-06-06
HU228889B1 (en) 2013-06-28
KR20010101192A (ko) 2001-11-14
FR2787028B1 (fr) 2002-10-18
CZ20012085A3 (cs) 2001-09-12
KR100641473B1 (ko) 2006-10-31
SK285206B6 (sk) 2006-08-03
ATE278401T1 (de) 2004-10-15
US6660757B2 (en) 2003-12-09
WO2000035447A1 (fr) 2000-06-22
CA2355359C (fr) 2009-02-03
BR9916244A (pt) 2001-10-02
NO326764B1 (no) 2009-02-09
HUP0104698A3 (en) 2004-05-28
IL143280A (en) 2007-10-31
JP2002532424A (ja) 2002-10-02
AU1569600A (en) 2000-07-03

Similar Documents

Publication Publication Date Title
WO2000038786A3 (en) Use of cyclooxygenase 2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia
ATE340171T1 (de) Piperazinderivate zur behandlung bakterieller infektionen
EP1231914A4 (en) NORDIHYDROGUAIARTIC DERIVATIVES FOR USE IN THE TREATMENT OF TUMORS
NZ509729A (en) Agents with an antidepressive effect
EE05056B1 (et) IL-18 inhibiitorite kasutamine ravimi valmistamiseks, mis on ette n„htud ateroskleroosi ravimiseks ja/v?i ennetamiseks
HK1030885A1 (en) The use of isatin and oxindole derivatives in the preparation of a medicament for use in the treatment of mycobacterial disease
HK1038692A1 (zh) 治療眼、耳、鼻病症的抗生素合成劑
ZA200201819B (en) Preventive and therapeutic agents for eye diseases.
GB9804886D0 (en) Therapeutic combination
ZA200003768B (en) Methods and compositions for treating diseases and conditions of the eye.
AU2476200A (en) Ribozyme therapy for the treatment and/or prevention of restenosis
AU1556497A (en) Agents for the treatment and prevention of aids
TR199900505T2 (ja)
IL143280A0 (en) Use of riluzole for treating acoustic traumas
BG105962A (en) Use of saredutant and the pharmaceutically acceptable salts thereof to produce medicaments used to treat or prevent mood disorders, adjustment disorders or mixed anxiety-depression disorders
EP0681787A3 (en) Use of an enzyme for the manufacture of an agent suitable for the treatment and / or prophylaxis of coccidiosis.
NZ525774A (en) Use of SARP-1 for the treatment and/or prevention of scleroderma
DK1133296T3 (da) Ny terapeutisk anvendelse af nicergolin
IL130968A0 (en) Pharmaceutical composition useful for the treatment of tinnitus and hearing loss
GB9802542D0 (en) New use
WO2001041769A3 (fr) Association de cyamemazine et d'un neuroleptique atypique
ZA200105473B (en) Utilisation of 2-substituted 1,2-benzisothiazole derivatives and 3-substituted tetrahydropyridopyrimidinone derivatives for the prophylaxis and therapy of cerebral ischaemia.
IL139303A0 (en) Treatment of arthritis and other similar conditions
AU2177401A (en) Combination of riluzole and gabapentin and use thereof as medicine
WO2000027376A3 (de) Verwendung von thiolverbindungen, oxidoreduktasen und/oder hydrolasen zur behandlung des tinnitus, insbesondere des chronischen tinnitus

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed